Shuttle Pharmaceuticals Holdings, Inc. SEC filings SHPH
Shuttle Pharmaceuticals Holdings, Inc. has 307 filings in SEC EDGAR's recent list, going back to Jan 31, 2019. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Sep 24, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (auditor change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-Q | Filing | Aug 17, 2026 | Jun 30, 2026 |
| D | Filing | May 15, 2026 | — |
| EFFECT | Filing | Feb 17, 2026 | — |
| CORRESP | Letter to the SEC | Feb 13, 2026 | — |
| CORRESP | Letter to the SEC | Feb 13, 2026 | — |
| EFFECT | Filing | Jan 30, 2026 | — |
| CORRESP | Letter to the SEC | Jan 29, 2026 | — |
| CORRESP | Letter to the SEC | Jan 20, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2026 | — |
| CORRESP | Letter to the SEC | Dec 29, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2025 | — |
| DRS | Filing | Dec 3, 2025 | — |
| D | Filing | Nov 7, 2025 | — |
| EFFECT | Filing | Aug 11, 2025 | — |
| CORRESP | Letter to the SEC | Aug 8, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2025 | — |
| D | Filing | Jun 26, 2025 | — |
| PRER14A | Filing | Apr 22, 2025 | — |
| DEFR14A | Filing | Apr 21, 2025 | — |
| PRER14A | Filing | Apr 10, 2025 | — |
| EFFECT | Filing | Mar 7, 2025 | — |
| CORRESP | Letter to the SEC | Mar 6, 2025 | — |
| CORRESP | Letter to the SEC | Mar 6, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 19, 2025 | — |
| EFFECT | Filing | Jan 23, 2025 | — |
| RW | Filing | Jan 22, 2025 | — |
| CORRESP | Letter to the SEC | Jan 21, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 21, 2025 | — |
| EFFECT | Filing | Oct 29, 2024 | — |
| CORRESP | Letter to the SEC | Oct 25, 2024 | — |
| CORRESP | Letter to the SEC | Oct 25, 2024 | — |
| D | Filing | Oct 25, 2024 | — |
| CORRESP | Letter to the SEC | Oct 18, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 4, 2024 | — |
| NT 10-Q | Filing | Aug 13, 2024 | Jun 30, 2024 |
| NT 10-Q | Filing | May 15, 2023 | Mar 31, 2023 |
| EFFECT | Filing | Feb 1, 2023 | — |
| CORRESP | Letter to the SEC | Jan 30, 2023 | — |
| CORRESP | Letter to the SEC | Jan 27, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2023 | — |
| CORRESP | Letter to the SEC | Jan 25, 2023 | — |
| D | Filing | Jan 20, 2023 | — |
| DRS | Filing | Sep 29, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2022 | — |
| EFFECT | Filing | Aug 29, 2022 | — |
| CERT | 8a cert | Aug 29, 2022 | — |
| 8-A12B | Filing | Aug 29, 2022 | — |
| CORRESP | Letter to the SEC | Aug 25, 2022 | — |
| CORRESP | Letter to the SEC | Aug 23, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 23, 2022 | — |
| D | Filing | Aug 15, 2022 | — |
| CORRESP | Letter to the SEC | Jul 12, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 29, 2022 | — |
| CORRESP | Letter to the SEC | Jun 23, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 15, 2022 | — |
| CORRESP | Letter to the SEC | Jun 3, 2022 | — |
| UPLOAD | Letter from the SEC | May 16, 2022 | — |
| DRS/A | Filing | Apr 26, 2022 | — |
| DRSLTR | Filing | Apr 25, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 18, 2022 | — |
| D | Filing | Feb 22, 2022 | — |
| DRS/A | Filing | Feb 11, 2022 | — |
| DRS/A | Filing | Feb 11, 2022 | — |
| DRS/A | Filing | Feb 11, 2022 | — |
| DRSLTR | Filing | Feb 10, 2022 | — |
| D | Filing | Jan 4, 2022 | — |
| DRS | Filing | Sep 16, 2019 | — |
| D | Filing | Jan 31, 2019 | — |
Showing 68 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SHPH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Gaithersburg, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1757499
- Former names
- Shuttle Pharmaceuticals Holdings, Inc. (until Oct 22, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.